Category: US Pharmaceuticals

FDA Authorizes Third Dose of Pfizer, Moderna Vaccines for Immunocompromised Patients

The FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

Read More
Loading